Ocean Other Current Assets from 2010 to 2024

OCEAW Stock   0.04  0.01  14.25%   
Ocean Biomedical Other Current Assets yearly trend continues to be fairly stable with very little volatility. Other Current Assets will likely drop to about 76.7 K in 2024. Other Current Assets is assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories. View All Fundamentals
 
Other Current Assets  
First Reported
2010-12-31
Previous Quarter
80.7 K
Current Value
76.7 K
Quarterly Volatility
130.8 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Ocean Biomedical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ocean Biomedical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.8 M, Selling General Administrative of 34.3 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 3.44. Ocean financial statements analysis is a perfect complement when working with Ocean Biomedical Valuation or Volatility modules.
  
Check out the analysis of Ocean Biomedical Correlation against competitors.
For more information on how to buy Ocean Stock please use our How to Invest in Ocean Biomedical guide.

Latest Ocean Biomedical's Other Current Assets Growth Pattern

Below is the plot of the Other Current Assets of Ocean Biomedical over the last few years. It is assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories. Ocean Biomedical's Other Current Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Ocean Biomedical's overall financial position and show how it may be relating to other accounts over time.
Other Current Assets10 Years Trend
Slightly volatile
   Other Current Assets   
       Timeline  

Ocean Other Current Assets Regression Statistics

Arithmetic Mean331,158
Geometric Mean287,204
Coefficient Of Variation39.48
Mean Deviation99,519
Median386,000
Standard Deviation130,756
Sample Variance17.1B
Range397.6K
R-Value(0.63)
Mean Square Error11.2B
R-Squared0.39
Significance0.01
Slope(18,305)
Total Sum of Squares239.4B

Ocean Other Current Assets History

202476.7 K
202380.7 K
202289.7 K
2021474.3 K

About Ocean Biomedical Financial Statements

Ocean Biomedical investors use historical fundamental indicators, such as Ocean Biomedical's Other Current Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Ocean Biomedical. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Other Current Assets80.7 K76.7 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Ocean Stock Analysis

When running Ocean Biomedical's price analysis, check to measure Ocean Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ocean Biomedical is operating at the current time. Most of Ocean Biomedical's value examination focuses on studying past and present price action to predict the probability of Ocean Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ocean Biomedical's price. Additionally, you may evaluate how the addition of Ocean Biomedical to your portfolios can decrease your overall portfolio volatility.